TrialLeukemia2005
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
S Verheyden et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papertrialcites it